Iron Chelation in Patients with Transfusion Dependent Thalassemia: An Insight on Response to Deferasirox

被引：0
|
作者：
Shaikh, Muhammad Shariq [1 ]
Adil, Salman Naseem [1 ]
机构：
[1] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2015年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [1] Recent insight on improving the iron chelation efficacy of deferasirox by adjuvant therapy in transfusion dependent beta thalassemia children with sluggish response
    Hamed, Eman Mostafa
    Meabed, Mohamed Hussein
    Hussein, Raghda R. S.
    Aly, Usama Farghaly
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (03) : 179 - 193
  • [2] COMBINED CHELATION THERAPY WITH DEFERASIROX AND DEFEROXAMINE IN TRANSFUSION-DEPENDENT PATIENTS WITH THALASSEMIA
    Ladis, V.
    Delaporta, P.
    Kyriakopoulou, D.
    Kattamis, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 703 - 703
  • [3] Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia
    Lal, Ashutosh
    Sweeters, Nancy
    Ng, Vivian
    Foote, Drucilla
    Evans, Patricia
    Neumayr, Lynne
    Kurio, Gregory
    Harmatz, Paul
    Porter, John B.
    Vichinsky, Elliott
    [J]. BLOOD, 2010, 116 (21) : 1732 - 1733
  • [4] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [5] Iron Chelation with Deferasirox in Thalassemia Major Patients with Low Iron Burdens and Moderate to High Transfusion Regimens.
    Evans, Elizabeth
    Kleinert, Dorothy A.
    Mennitt, Kevin
    Grady, Robert W.
    Giardina, Patricia J.
    [J]. BLOOD, 2009, 114 (22) : 1562 - 1562
  • [6] Transfusion Dependent MDS-Patients benefit from Iron Chelation with Exjade®(Deferasirox)
    不详
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (06) : 471 - 471
  • [7] Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
    Michael D. Diamantidis
    Nikolaos Neokleous
    Aleka Agapidou
    Evaggelia Vetsiou
    Achilles Manafas
    Paraskevi Fotiou
    Efthymia Vlachaki
    [J]. International Journal of Hematology, 2016, 103 : 537 - 544
  • [8] Iron Chelation Therapy in Transfusion Dependent Patients with Thalassemia and Minimal Liver Iron Load
    Kattamis, Antonios
    Stokidis, Konstantinos
    Petropoulou, Tbeoni
    Kyriacopoulou, Dimitra
    Delaporta, Polyxeni
    Papassptiriou, Ioannis
    Ladis, Vassilis
    [J]. BLOOD, 2010, 116 (21) : 1733 - 1733
  • [9] Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
    Diamantidis, Michael D.
    Neokleous, Nikolaos
    Agapidou, Aleka
    Vetsiou, Evaggelia
    Manafas, Achilles
    Fotiou, Paraskevi
    Vlachaki, Efthymia
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (05) : 537 - 544
  • [10] Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia
    Trachtenberg, Felicia
    Vichinsky, Elliott
    Haines, Dru
    Pakbaz, Zahra
    Mednick, Lauren
    Sobota, Amy
    Kwiatkowski, Janet
    Thompson, Alexis A.
    Porter, John
    Coates, Thomas
    Giardina, Patricia J.
    Olivieri, Nancy
    Yamashita, Robert
    Neufeld, Ellis J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (05) : 433 - 436
12345